Sagimet (SGMT) Shares Surge After FDA Grants Key Therapy Designation
Fahim Awan
October 1, 2024
With shares rising 8.50% to $3.00 as of the most recent check, Sagimet Biosciences Inc. (NASDAQ: SGMT) is witnessing a noteworthy increase in its stock